Acute Myeloid Leukemia

Overview

4.6 out of 5 (139 Reviews)

Credits

1.50

Post Assessment Questions

9

Start Date

1 Sep 2023

Last Review Date

27 Apr 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Acute myeloid leukemia (AML) is a rapidly progressing myeloid neoplasm characterized by the clonal expansion of primitive hematopoietic stem cells, known as blasts, in the bone marrow. This expansion results in ineffective erythropoiesis and megakaryopoiesis, clinically manifesting as relatively rapid bone marrow failure compared to chronic and indolent leukemias. This leads to inadequate production of red blood cells and platelets. The recent consensus guidelines established by the European LeukemiaNET (ELN) in 2022 have emphasized molecular characterization and risk stratification for individuals with AML, providing updated data on these aspects.

Treatment options vary depending on patient-specific factors, and hematopoietic stem cell transplant remains the only curative therapy. Although the administration of multiagent induction chemotherapy can achieve complete remission, allogeneic stem cell transplantation is the only established curative therapy. Despite advancements in therapeutic approaches, prognosis remains suboptimal, especially among the older populations. This activity explores the appropriate timing for considering this condition in the differential diagnosis and outlines proper evaluation methods. In addition, this activity emphasizes the crucial role of the interprofessional healthcare team in providing care for patients affected by this condition.


UAN: JA4008338-0000-23-3056-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify characteristic clinical features and laboratory findings indicative of acute myeloid leukemia during patient evaluation.

  • Implement evidence-based diagnostic and therapeutic strategies for acute myeloid leukemia management in accordance with established guidelines.

  • Select appropriate induction and consolidation therapies tailored to individual patient characteristics and disease risk for patients with acute myeloid leukemia.

  • Collaborate with multidisciplinary healthcare teams to develop comprehensive care plans and provide support for patients throughout their acute myeloid leukemia journey.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.50 ACPE credit(s). (UAN: JA4008338-0000-23-3056-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Henrik H. on 2/8/2021

Deborah Z. on 2/11/2021

Mrs W. on 7/25/2021

section on treatment was short and vague. as a pharmacist, I'd have liked to learn more about treatment

Trista P. on 8/17/2021

Tamara L. on 9/8/2021

Kelli B. on 9/27/2021

MOSFER A. on 9/4/2022

on 12/27/2021

Laurie T. on 1/2/2022

Timothy M. on 2/16/2022

Jennifer K. on 2/25/2022

Tamara L. on 3/14/2022

PATIENCE A. on 5/18/2022

sherman y. on 5/30/2022

Morgan P. on 6/29/2022

Amy S. on 7/13/2022

Vonda R. on 8/19/2022

Sarah B. on 9/21/2022

Theodore B. on 10/25/2022

Sara M. on 10/27/2022

Vektra C. on 12/26/2022

Well done presentation and a very nice review of AML. Thank you!

Mathew M. on 12/27/2022

Larry E. on 2/19/2023

Adi F. on 2/24/2023

Jess P. on 4/11/2023

Daniel H. on 4/11/2023

Aseeb R. on 4/15/2023

Jamie K. on 4/17/2023

Sunita N. on 5/19/2023

cynthia s. on 6/15/2023

Ashley W. on 6/30/2023

Susan f. on 7/7/2023

Cerise M. on 7/12/2023

Samantha P. on 7/26/2023

kimberly g. on 8/8/2023

Diana S. on 8/23/2023

Kelly K. on 8/26/2023

Mary Y. on 8/28/2023

Michael Y. on 9/3/2023

Steven S. on 9/8/2023

Dr Sruthi G. on 9/20/2023

Liam M. on 9/18/2023

Essam M. on 9/19/2023

Tanya H. on 9/30/2023

Thanks

Matthew C. on 10/2/2023

Susan N. on 10/4/2023

Richard C. on 10/8/2023

Jami P. on 10/18/2023

louis v. on 10/22/2023

John M. on 10/24/2023

Melissa B. on 10/26/2023

LEILANY I. on 10/29/2023

Mohammed J. on 10/29/2023

HARRY Y. on 10/29/2023

Ralph C. on 10/30/2023

Juan H. on 11/3/2023

Helen d. on 11/5/2023

DELALI A. on 11/5/2023

Mohamed E. on 11/20/2023

Everett M. on 11/11/2023

James S. on 11/12/2023

Elisabeth I. on 11/16/2023

Christopher K. on 11/24/2023

Edward F. on 11/27/2023

SILVIO M. on 11/29/2023

kristi f. on 11/30/2023

Good review.

Richard P. on 12/3/2023

None

Daniel A. on 12/4/2023

ROBERT M. on 12/8/2023

Brian M. on 12/11/2023

Kathleen C. on 12/14/2023

Ranjana S. on 12/17/2023

Scott S. on 12/18/2023

William e. on 12/18/2023

Aviva Z. on 12/19/2023

Richard S. on 12/20/2023

Adrian d. on 12/23/2023

mohamad a. on 12/25/2023

arvind b. on 12/28/2023

francisco B. on 12/28/2023

Kimberly G. on 12/28/2023

Melissa W. on 12/28/2023

Mary H. on 12/28/2023

Jyotsna on 12/29/2023

Maria N. on 1/6/2024

Zhengyi C. on 1/13/2024

osei b. on 1/14/2024

Trishala A. on 1/20/2024

Lisa C. on 1/23/2024

zafar n. on 1/24/2024

Stephanie E. on 1/28/2024

Adrian G. on 1/30/2024

Patricia S. on 1/30/2024

Kerry W. on 1/31/2024

Yongmei J. on 2/17/2024

ISLAM A. on 2/19/2024

Steven S. on 2/20/2024

Said a. on 2/26/2024

shahid m. on 2/27/2024

ROXANNA R. on 2/28/2024

Kaman C. on 3/4/2024

homam a. on 3/8/2024

Tyler J. on 3/10/2024

Mark K. on 3/16/2024

Olusanya R. on 3/17/2024

hans r. on 3/18/2024

Maureen H. on 3/18/2024

Luis P. on 3/21/2024

Yago N. on 3/27/2024

Thank you

Thomas S. on 3/27/2024

larry m. on 4/3/2024

Zahid Q. on 4/3/2024

Bozena B. on 4/3/2024

Julie C. on 4/3/2024

Tiffany M. on 4/5/2024

Mohammad G. on 4/5/2024

Yashpal m. on 4/5/2024

David R. on 4/6/2024

Fabian L. on 4/9/2024

cyrus i. on 4/10/2024

Ralph C. on 4/17/2024

Carolyn F. on 4/23/2024

Tara G. on 4/24/2024

Victor W M. on 4/26/2024

musib g. on 5/5/2024

DUSTIN S. on 5/6/2024

keith C. on 5/13/2024

ishvar p. on 5/16/2024

Ty m. on 5/19/2024

Rajat V. on 5/24/2024

Azzam A. on 6/4/2024

Linda T. on 6/21/2024

Alison M. on 6/22/2024

Elisa S. on 6/28/2024

Clay S. on 7/4/2024

Durathun F. on 7/10/2024

Ikechukwu A. on 7/13/2024

Glenn T. on 7/15/2024

Mark M. on 7/19/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user